Market Size of Saudi Arabia Self-Monitoring Blood Glucose Devices Industry
| Study Period | 2017-2028 |
| Base Year For Estimation | 2022 |
| Forecast Data Period | 2024 - 2028 |
| Historical Data Period | 2018 - 2021 |
| CAGR | 6.42 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Saudi Arabia Self-Monitoring Blood Glucose Devices Market Analysis
The Saudi Arabia self-monitoring blood glucose devices market is expected to register a CAGR of 6.4% and reach a value of about USD 147 million over the forecast period.
Patients with diabetes infected with COVID-19 experienced elevated blood glucose, abnormal glucose variability, and diabetic complications. The prevalence of diabetes in people with COVID-19 caused a significant increase in the severity and mortality of COVID-19 in people with either type-1 or type-2 diabetes mellitus, especially in association with poor glycemic control. As diabetes already ranked higher among the major health issues in Saudi Arabia, there was an urgent need to provide an enhanced understanding of self-management, follow-up care, and glycemic management. While new-onset hyperglycemia and new-onset diabetes were increasingly recognized in the context of COVID-19 and associated with worse outcomes.
Blood glucose monitoring increases patients’ awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values provide feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and additional relevant data such as insulin doses, meals, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.
